Buscar
PepGen Inc
PEPGAñadir a la lista de seguimiento
2.980USD
0.0000.00%
Horarios del mercado 09/14, 13:22（ET）
206.39MCap. mercado
PérdidaP/E TTM
Más Datos de PepGen Inc Compañía
PepGen Inc. is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies. The Company’s Enhanced Delivery Oligonucleotide (EDO) platform leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake and nuclear delivery. Using these EDO peptides, the Company is generating a pipeline of oligonucleotide therapeutic candidates designed to target the root cause of serious diseases. It is focused on addressing the underlying cause of Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1), which have high unmet need. Its pipeline consists of two clinical stage programs, PGN-EDO51 for DMD patients who are amenable to an exon 51-skipping approach and PGN-EDODM1 for DM1 patients, and several additional preclinical stage programs. Its product candidates also include PGN-EDO53, PGN-EDO45 and PGN-EDO44.
Perfil de PepGen Inc
Símbolo de cotizaciónPEPG
Nombre de la empresaPepGen Inc
Fecha de salida a bolsaMay 06, 2022
Director ejecutivoMcArthur (James G)
Número de empleados81
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 06
Dirección245 Main St, 2nd Floor
CiudadCAMBRIDGE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal02142
Teléfono17034568000
Sitio Webhttps://pepgen.com
Símbolo de cotizaciónPEPG
Fecha de salida a bolsaMay 06, 2022
Director ejecutivoMcArthur (James G)
Ejecutivos de PepGen Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. James G. McArthur, Ph.D.
Dr. James G. McArthur, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.10K
+15.70%
Dr. James G. McArthur, Ph.D.
Dr. James G. McArthur, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.10K
+15.70%
Mr. Noel P. Donnelly
Mr. Noel P. Donnelly
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Joshua B. (Josh) Resnick, M.D.
Dr. Joshua B. (Josh) Resnick, M.D.
Independent Director
Independent Director
--
--
Ms. Heidi Henson, CPA
Ms. Heidi Henson, CPA
Independent Director
Independent Director
--
--
Ms. Laurie Bartlett Keating, J.D.
Ms. Laurie Bartlett Keating, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Habib Joseph Dable
Mr. Habib Joseph Dable
Independent Director
Independent Director
--
--
Dr. Howard Mayer, M.D.
Dr. Howard Mayer, M.D.
Independent Director
Independent Director
--
--
Dr. Paul D. Streck, M.D.
Dr. Paul D. Streck, M.D.
Executive Vice President, Head of Research and Development
Executive Vice President, Head of Research and Development
--
--
Dr. Mitchell H. Finer, Ph.D.
Dr. Mitchell H. Finer, Ph.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. James G. McArthur, Ph.D.
Dr. James G. McArthur, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.10K
+15.70%
Dr. James G. McArthur, Ph.D.
Dr. James G. McArthur, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.10K
+15.70%
Mr. Noel P. Donnelly
Mr. Noel P. Donnelly
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Joshua B. (Josh) Resnick, M.D.
Dr. Joshua B. (Josh) Resnick, M.D.
Independent Director
Independent Director
--
--
Ms. Heidi Henson, CPA
Ms. Heidi Henson, CPA
Independent Director
Independent Director
--
--
Ms. Laurie Bartlett Keating, J.D.
Ms. Laurie Bartlett Keating, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de PepGen Inc?
Los cinco principales accionistas de PepGen Inc son: Dr. James G. McArthur, Ph.D.
¿Cuántas instituciones poseen acciones de PepGen Inc (PEPG)?
A fecha de 2026Q1, 209 instituciones poseen acciones de PepGen Inc, con un valor de mercado combinado de aproximadamente 66.38M, lo que representa el 95.96% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -2071901.00.